Pharmaceutical Investing Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon
Pharmaceutical Investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
Pharmaceutical Investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
Pharmaceutical Investing Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for Advanced Parkinson’s Disease
Brunswick Exploration Drills 36 Meters at 1.51% and Continues to Extend the Mineralized Footprint of Mirage
